Prof. SEMRA PAYDAŞ

Küçükgöz Güleç Ü., Paydaş S., Güzel A. B.

MEDICAL ONCOLOGY , vol.38, no.3, 2021 (SCI-Expanded, Scopus)

37. Assessment of Prognostic Factors and Adjuvant Treatment Modalities in Adult Head and Neck Soft Tissue Sarcoma Patients Treated With Upfront Surgery

Akagunduz B., Telli T. A., SEZGİN GÖKSU S., YILDIRIM H. Ç., Ozer M., Aydin S. G., et al.

CUREUS , vol.13, no.2, 2021 (ESCI)

38. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Sezer A., Kılıçkap S., Gümüş M., Bondarenko I., Özgüroğlu M., Gogishvili M., et al.

LANCET , vol.397, no.10274, pp.592-604, 2021 (SCI-Expanded, Scopus) Sustainable Development

39. Tamoksifen Kullanan Hastaların Jinekolojik Yönden Değerlendirilmesi

Arşiv Kaynak Tarama Dergisi , vol.30, no.1, pp.45-51, 2021 (TRDizin)

40. Worse patient-physician relationship is associated with more fear of cancer recurrence (Deimos Study): A study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

Alkan A., Yasar A., Guc Z. G., Gurbuz M., BAŞOĞLU TÜYLÜ T., SEZGİN GÖKSU S., et al.

EUROPEAN JOURNAL OF CANCER CARE , vol.29, no.6, 2020 (SCI-Expanded, SSCI, Scopus) Sustainable Development

41. Tafro syndrome from a single center outside Japan: 3 cases and review of the literature

KUZU T., PAYDAŞ S., KURTARAN B., PAYDAŞ S., kılıç bağır e., ERGİN M.

HEMATOLOGY ONCOLOGY CURRENT RESEARCH , no.3, pp.1005, 2020 (Peer-Reviewed Journal)

42. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients

Peled N., Gillis R., KILIÇKAP S., Froesch P., Orlov S., Filippova E., et al.

LUNG CANCER , vol.148, pp.48-54, 2020 (SCI-Expanded, Scopus)

43. Demographical and Clinical Features of Marginal Zone Lymphomas: A Retrospective Study of Turkish Oncology Group (TOG)

Turkkan G., Alkan A., PAYDAŞ S., TANRIVERDİ Ö., Karakas Y., Karadurmus N., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.36, no.4, pp.640-645, 2020 (SCI-Expanded, Scopus)

44. Prognosis Trend of Grade 2 Endometrioid Endometrial Carcinoma: Toward Grade 1 or 3?

KHATİB G., Gulec Ü., GÜZEL A. B., Bagir E., PAYDAŞ S., VARDAR M. A.

PATHOLOGY & ONCOLOGY RESEARCH , vol.26, no.4, pp.2351-2356, 2020 (SCI-Expanded, Scopus) Sustainable Development

45. Inflammatory Markers Predicting Pathological Complete Response in Cases with Breast Cancer Treated by Neoadjuvant Chemotherapy

Buyuksimsek M., Ogul A., Mirilli C., PAYDAŞ S.

EUROPEAN JOURNAL OF BREAST HEALTH , vol.16, no.4, pp.229-234, 2020 (ESCI, TRDizin) Sustainable Development

46. Predictive Biomarkers in Late Onset Neutropenia Associatedwith Rituximab

OĞUL A., PAYDAŞ S., YETİŞİR A. E., MİRİLİ C., BÜYÜKŞİMŞEK M.

Eurasian Journal of Medical Investigation , vol.4, no.4, pp.428-432, 2020 (TRDizin)

47. Early Access Program Results From Turkey and a Literature Review on Daratumumab Monotherapy Among Heavily Pretreated Patients With Relapsed/Refractory Myeloma

BEKSAÇ M., Aydin Y., GÖKER H., Turgut M., Besisik S. K., Cagirgan S., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.20, no.8, 2020 (SCI-Expanded, Scopus)

48. Clinical Features and Treatment Results of Metastatic Breast Cancer Patients: A Single Center Experience

BÜYÜKŞİMŞEK M., PAYDAŞ S., Togun M., yetişir a. e., MİRİLİ C., OĞUL A., et al.

ANADOLU KLİNİĞİ TIP BİLİMLERİ DERGİSİ , vol.25, no.2, pp.75-85, 2020 (TRDizin) Sustainable Development

49. LENFOMA HASTALARINDA HEPATİT B VE C PREVALANSININ DEĞERLENDİRİLMESİ

BÜYÜKŞİMŞEK M., TOĞUN M., yetişir a. e., MİRİLİ C., OĞUL A., TOHUMCUOĞLU M., et al.

Namık Kemal Tıp Dergisi , vol.8, no.1, pp.48-51, 2020 (TRDizin) Sustainable Development

50. Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

Demir A., Mandel N. M., PAYDAŞ S., Demir G., ER O., Turhal N. S., et al.

BALKAN MEDICAL JOURNAL , vol.37, no.2, pp.104-107, 2020 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

51. Does primary tumor localization has prognostic importance in seminoma patients?: Turkish Oncology Group Study

Yildiz B., Kucukarda A., Gokyer A., Demiray A. G., PAYDAŞ S., Aral I. P., et al.

JOURNAL OF BUON , vol.25, no.2, pp.1130-1135, 2020 (SCI-Expanded, Scopus)

52. Obez endometroid endometrial kanserli olgulara pelvik lenfadenektomiye paraaortik lenfadenektomi eklenmesinin sağkalıma etkisi

KHATİB G., VARDAR M. A., GÜZEL A. B., KÜÇÜKGÖZ GÜLEÇ Ü., SEYFETTİNOĞLU S., BAYAT B., et al.

Cukurova Medical Journal , vol.45, no.1, pp.134-140, 2020 (ESCI, TRDizin) Sustainable Development

53. Perspective of Turkish Medicine Students on Cancer, Cancer Treatments, Palliative Care, and Oncologists (ARES Study): a Study of the Palliative Care Working Committee of the Turkish Oncology Group (TOG)

Oktay E., Levent M., Gelincik H., Aktas G., Yumuk F., KORAL L., et al.

JOURNAL OF CANCER EDUCATION , vol.35, no.1, pp.69-75, 2020 (SCI-Expanded, Scopus) Sustainable Development

54. Long-term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience

Ozbalak M., SALİHOĞLU A., Soysal T., Karadogan I., PAYDAŞ S., Ozdemir E., et al.

ANNALS OF HEMATOLOGY , vol.99, no.2, pp.301-307, 2020 (SCI-Expanded, Scopus)

55. Pulmonary hyalinizing granuloma with castleman

AÇIKALIN A., KILIÇ BAĞIR E., AKSIN M., GÜMÜRDÜLÜ D., ERGİN M., PAYDAŞ S.

Journal of Current Pathology , vol.4, no.1, pp.5, 2020 (Peer-Reviewed Journal)

56. The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA

Disel U., Madison R., Abhishek K., Chung J. H., Trabucco S. E., Matos A. O., et al.

ONCOLOGIST , vol.25, no.1, 2020 (SCI-Expanded, Scopus) Sustainable Development

57. The survival impact of adding paraaortic lymphadenectomy to pelvic lymphadenectomy in the obese endometrioid endometrial cancer cases

Khatib G., VARDAR M. A., GÜZEL A. B., KÜÇÜKGÖZ GÜLEÇ Ü., Seyfettinoglu S., Bayat B., et al.

CUKUROVA MEDICAL JOURNAL , vol.45, no.1, pp.134-140, 2020 (ESCI, TRDizin) Sustainable Development

58. Prognostic significance of EGFR, MUC1 and PD-L1 expressions in cases with triple negative breast cancer

MİRİLİ C., PAYDAŞ S., BAĞIR KILIÇ E., SEYDAOĞLU G., OĞUL A., GÖKÇAY S., et al.

JOURNAL OF BUON , vol.25, no.1, pp.159-167, 2020 (SCI-Expanded, Scopus) Sustainable Development

59. Efficacy of Prephase Treatment for the Prevention of Tumor Lysis Syndrome in Lymphoma Cases with High Tumor Burden: A Cross-Sectional Study

Ogul A., PAYDAŞ S., Buyuksimsek M., Yetisir A. E.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.30, no.2, pp.87-93, 2020 (SCI-Expanded, Scopus, TRDizin)

60. Cerebral MRI Mimicking Pachymeningeal Involvement Associated with Intrathecal Treatment

PAYDAŞ S., Bicakci K.

TURKISH JOURNAL OF HEMATOLOGY , vol.37, no.4, pp.308-309, 2020 (SCI-Expanded, Scopus, TRDizin)

61. Dynamic prognostic nutritional index could be a novel predictor of survival in lung cancer patients treated with nivolumab

MİRİLİ C., PAYDAŞ S., OĞUL A., GÖKÇAY S., BÜYÜKŞİMŞEK M., YETİŞİR A. E., et al.

ANNALS OF CLINICAL AND ANALYTICAL MEDICINE , vol.11, pp.1-6, 2020 (ESCI) Sustainable Development

62. Factors predicting prognosis with oncology patients followed in the intensive care unit

OĞUL A., PAYDAŞ S., KARAKOÇ E., ŞEYDAOĞLU G., BÜYÜKŞİMŞEK M.

CUKUROVA MEDICAL JOURNAL , vol.45, no.4, pp.1267-1275, 2020 (ESCI, TRDizin)

63. Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma

Gulec Ü., Bagir E. K., PAYDAŞ S., GÜZEL A. B., GÜMÜRDÜLÜ D., VARDAR M. A.

EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , vol.244, pp.51-55, 2020 (SCI-Expanded, Scopus)

64. Prognostic significance of PRAME (preferentially expressed antigen of melanoma) expression in breast cancer

DALCI K., Kekec Y., PAYDAŞ S., ZORLUDEMİR S., ERGİN M., Tanriverdi K., et al.

CUKUROVA MEDICAL JOURNAL , vol.45, no.3, pp.1202-1209, 2020 (ESCI, TRDizin) Sustainable Development

65. LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGLE INSTITUTION

MİRİLİ C., PAYDAŞ S., BÜYÜKŞİMŞEK M., TOHUMCUOĞLU M., yetişir a. e., OĞUL A.

Namık Kemal Medical Journal (NKMJ) , vol.7, no.3, pp.271-278, 2019 (TRDizin)

66. Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma

Mirili C., PAYDAŞ S., Kapukaya T. K., YILMAZ A.

BIOMARKERS IN MEDICINE , vol.13, no.18, pp.1565-1575, 2019 (SCI-Expanded, Scopus)

67. LONG-TERM OUTCOME OF SOFT TISSUE SARCOMAS TREATED WITH MESNA-DOXORUBICIN-IFOSFAMID-DACARBAZINE REGIMEN (MAID): A RETROSPECTIVE STUDY FROM A SINGE INSTITUTION

MIRILI C., PAYDAŞ S., BUYUKSIMSEK M., TOHUMCUOĞLU M.

Namık Kemal Tıp Dergisi , 2019 (TRDizin)

68. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable >= Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

BEKSAÇ M., Seval G. C., PAYDAŞ S., Tuglular T. F., ARSLAN Ö., GÖKER H., et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , vol.19, no.10, 2019 (SCI-Expanded, Scopus)

69. Clinic, Prognostic and Predictive Value of Circulating Tumor DNA in Lymphomas

KÜÇÜKGÖZ GÜLEÇ Ü., BAĞIR KILIÇ E., PAYDAŞ S., GÜZEL A. B., GÜMÜRDÜLÜ D., VARDAR M. A.

LLM Dergi , vol.3, no.3, pp.45-50, 2019 (TRDizin)

70. Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.300, no.2, pp.377-382, 2019 (SCI-Expanded, Scopus) Sustainable Development

71. Orbital extramedullary leukaemia is not a rare entity

BRITISH JOURNAL OF HAEMATOLOGY , vol.186, no.3, 2019 (SCI-Expanded, Scopus)

72. Pancreatic plasmacytoma: A rare but important entity for gastroenterologists, oncologists and hematologists

Journal of Oncological Sciences , vol.5, no.3, pp.109-111, 2019 (TRDizin)

73. Are Uterine Grade 3 Endometrioid Adenocarcinoma and Carcinosarcoma Really Clinically Similar?

Gulec U. K., PAYDAŞ S., GÜMÜRDÜLÜ D., GÜZEL A. B., Bagir E. K., VARDAR M. A.

INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY , vol.17, no.2, 2019 (ESCI, Scopus)

74. Management of adverse effects/toxicity of ibrutinib

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.136, pp.56-63, 2019 (SCI-Expanded, Scopus) Sustainable Development

75. Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC)

Mirili C., Güney İ. B., Paydaş S., Seydaoğlu G., Kapukaya T. K., Oğul A., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , vol.24, no.2, pp.168-178, 2019 (SCI-Expanded, Scopus)

76. Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI)

MIRILI C., PAYDAŞ S., YILMAZ A., OGUL A., BUYUKSIMSEK M., YETISIR A. E., et al.

Acta Oncologica Turcica , vol.52, no.3, pp.372-378, 2019 (TRDizin)

77. Effect of neoadjuvant chemotherapy on estrogen receptor, progesterone receptor, Cerb-B-2, vascular endothelial growth factor and Ki-67 in patients with locally advanced breast cancer

SARITAŞ A. G., YALAV O., Kekec Y., SAKMAN G., BAĞIR KILIÇ E., ZORLUDEMİR S., et al.

CUKUROVA MEDICAL JOURNAL , vol.44, no.1, pp.226-231, 2019 (ESCI, TRDizin) Sustainable Development

78. Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib

AÇIKALIN A., BAĞIR KILIÇ E., PAYDAŞ S., ALSANCAK P., ERGİN M.

CUKUROVA MEDICAL JOURNAL , vol.44, no.2, pp.395-401, 2019 (ESCI, TRDizin)

79. Tafro syndrome: Critical review for clinicians and pathologists

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.128, pp.88-95, 2018 (SCI-Expanded, Scopus)

80. PD-1 and PD-L1 expression in thymic epithelial tumours and non-neoplastic thymus.

Bagir E., Acikalin A., Avci A., Gumurdulu D., Paydas S.

Journal of clinical pathology , vol.71, pp.637-641, 2018 (SCI-Expanded, Scopus)

81. Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.

TEMUR I., Kucukgoz G., Paydas S., GÜZEL A. B., Sucu M., VARDAR M. A.

European journal of obstetrics, gynecology, and reproductive biology , vol.226, pp.25-29, 2018 (SCI-Expanded, Scopus) Sustainable Development

82. Malignant Mixed Müllerian Tumor of the Fallopian Tube: Rare Case

KHATİP G., SOYSAL C., KÜÇÜKGÖZ GÜLEÇ Ü., GÜZEL A. B., VARDAR M. A., KILIÇ BAĞIR E., et al.

Turkiye Klinikleri Journal of Gynecology and Obstetrics , vol.26, no.2, pp.55-57, 2018 (Scopus)

83. Merkel cell carcinoma in Turkey: A multicentric study.

Yildiz F., Buyuksimsek M., Sakalar T., Aydin O., Turna H., Babacan N. A., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018 (SCI-Expanded, Scopus)

84. EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC).

Paydas S., Mirili C., Bagir E., Seydaoglu G., Ogul A., Buyuksimsek M., et al.

JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018 (SCI-Expanded, Scopus) Sustainable Development

85. Effectiveness of platinum-based treatment for triple negative metastatic breast cancer: A meta-analysis

KAYA V., Yildirim M., YAZICI G., Gunduz S., BOZCUK H., Paydas S.

Asian Pacific Journal of Cancer Prevention , vol.19, no.5, pp.1169-1173, 2018 (SCI-Expanded, Scopus) Sustainable Development

86. Acute promyelocytic leukemia after anthracycline containing chemotherapy for breast cancer: Case report and review of the literature

MİRİLİ C., PAYDAŞ S., OĞUL A., GÖKÇAY S.

Journal of Oncological Sciences , vol.4, no.1, pp.62-64, 2018 (TRDizin) Sustainable Development

87. Hepatit C virüsü ve lenfoma ilişkisi: epidemiyoloji, patogenez, klinik özellikler ve tedavi

LLM Dergi , vol.2, no.1, pp.1-8, 2018 (TRDizin) Sustainable Development

88. Dynamic changes in PD-1 and PD-L1 expressions in cases with Hodgkin Lymphoma

Güney İ. B., PAYDAŞ S., BALLI H. T.

Clinical Research and Trials , vol.4, no.1, pp.1-5, 2018 (Peer-Reviewed Journal)

89. Pleural involvement in plasma cell neoplasm

Bahceci A., PAYDAŞ S., BAĞIR KILIÇ E., Uguz A.

CUKUROVA MEDICAL JOURNAL , vol.43, no.2, pp.498-499, 2018 (ESCI, TRDizin)

90. Pulmonary MALT lymphoma with underlying interstitial lung disease: A case report and rewiev of the literature

mirili c., PAYDAŞ S., oğul a., gökçay s., BÜYÜKŞİMŞEK M., YETİŞİR e., et al.

Journal of Oncological Sciences , vol.4, pp.56-59, 2018 (TRDizin)

91. Acetabular Metastasis as Initial Presentation of Endometrial Cancer

KHATİP G., CÖMERT E., KÜÇÜKGÖZ GÜLEÇ Ü., GÜZEL A. B., VARDAR M. A., KILIÇ BAĞIR E., et al.

Turkiye Klinikleri Journal of Case Reports , vol.26, no.1, pp.27-29, 2018 (TRDizin)

92. G-CSF related hemophagocytosıs in a case with lymhphoma

PAYDAŞ S., YETİŞİR E., MİRİLİ C., İSMAYİLOV E., BÜYÜKŞİMŞEK M., OĞUL A., et al.

Clinical Research and Trials , vol.4, no.1, pp.1-2, 2018 (Peer-Reviewed Journal)

93. Lymphocytic thyroiditis simulating thyroid cancer biochemically, radiologically and pathologicaly

IŞIK u., GÖKÇAY S., ŞİMŞEK M., PAYDAŞ S., BÜYÜKDERELİ G., UĞUZ A. H.

Journal of Oncological Sciences , vol.4, pp.114-115, 2018 (TRDizin) Sustainable Development

94. PROGRAMMED DEATH-1 (PD-1), PROGRAMMED DEATH-LIGAND 1 (PD-L1) EXPRESSION IN UTERINE GRADE 3 ENDOMETRIOID ADENOCANCER

Gulec U. K., Bagir E., PAYDAŞ S., GÜZEL A. B., KHATİB G., SEYDAOĞLU G., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.27, pp.1126, 2017 (SCI-Expanded, Scopus)

95. Super Scan Caused by Parathyroid Carcinoma Observed Both in<sup>18</sup>F-FDG PET/CT Scan and Tc-99m MDP Bone Scintigraphy.

Molecular imaging and radionuclide therapy , vol.26, pp.116-119, 2017 (ESCI, Scopus, TRDizin)

96. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience

Bekoz H., Karadurmus N., PAYDAŞ S., TÜRKER A., TOPTAŞ T., Tuglular T. F., et al.

ANNALS OF ONCOLOGY , vol.28, no.10, pp.2496-2502, 2017 (SCI-Expanded, Scopus)

97. THE EVALUATION OF HOPELESSNESS AND PERCEIVED SOCIAL SUPPORT LEVEL IN PATIENTS WITH LUNG CANCER

BOZDOĞAN S., ÖZTUNÇ G., YEŞİL DEMİRCİ P., İNEL MANAV A., PAYDAŞ S.

LIFE: International Journal of Health and Life-Sciences , vol.3, no.2, pp.88-105, 2017 (Peer-Reviewed Journal) Sustainable Development

98. Coexistence of hypertrophic osteoarthropathy and myelofibrosis

KELLE B., YILDIZ F., PAYDAŞ S., Bagir E. K., ERGİN M., KOZANOĞLU E.

REVISTA BRASILEIRA DE REUMATOLOGIA , vol.57, no.5, pp.472-474, 2017 (SCI-Expanded, Scopus)

99. THE EVALUATION OF HOPELESSNESS AND PERCEIVED SOCIAL SUPPORT LEVEL IN PATIENTS WITH LUNG CANCER

BOZDOĞAN S., ÖZTUNÇ G., YEŞİL DEMİRCİ P., İNEL MANAV A., PAYDAŞ S.

LIFE: International Journal of Health and Life-Sciences , vol.3, no.2, pp.88-105, 2017 (Peer-Reviewed Journal) Sustainable Development

100. THE EVALUATION OF HOPELESSNESS AND PERCEIVED SOCIAL SUPPORT LEVEL IN PATIENTS WITH LUNG CANCER

BOZDOĞAN S., ÖZTUNÇ G., YEŞİL DEMİRCİ P., İNEL MANAV A., PAYDAŞ S.

LIFE: International Journal of Health and Life-Sciences , vol.3, no.2, pp.88-105, 2017 (Peer-Reviewed Journal) Sustainable Development

101. Prevalence of cytogenetic abnormalities in chronic lymphocytic leukemia in the southern part of Turkey.

Bagir E., Acikalin A., Alsancak P., Paydas S., Gurkan E., Ergin M.

Indian journal of cancer , vol.54, pp.572-575, 2017 (SCI-Expanded, Scopus)

102. Primary central nervous system lymphoma: essential points in diagnosis and management

MEDICAL ONCOLOGY , vol.34, no.4, 2017 (SCI-Expanded, Scopus)

103. Gemcitabine-vinorelbine-prednisolone combination in cases with lymphoma: retrospective analysis

SÜRMELİOĞLU N., PAYDAŞ S., KARATAŞ Y., SEYDAOĞLU G.

Hematology Medical Oncology , vol.2, no.6, pp.2-5, 2017 (Peer-Reviewed Journal)

104. Attitudes of cancer patients after diagnosis: How cancer affects social life? A Turkish Oncology Group study

Nayir E., Koyuncu M. B., Esin E., Turker I., TANRIVERDİ Ö., UYSAL M., et al.

JOURNAL OF BUON , vol.22, no.1, pp.208-213, 2017 (SCI-Expanded, Scopus) Sustainable Development

105. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases

DEVECİ M. A., PAYDAŞ S., GÖNLÜŞEN G., ÖZKAN C., BİÇER Ö. S., TEKİN M.

ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA , vol.51, no.1, pp.1-6, 2017 (SCI-Expanded, Scopus, TRDizin)

106. Evaluation of lipid profiles in patients treated with capecitabine

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.47, no.4, pp.1206-1209, 2017 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

107. Clinicopathological features and prognostic factors of ovarian sex-cord stromal tumors

KOCAKI B., Gulec U. K., KHATİB G., GÜZEL A. B., GÜMÜRDÜLÜ D., PAYDAŞ S., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.38, no.5, pp.769-774, 2017 (SCI-Expanded, Scopus) Sustainable Development

108. MORPHOLOGIC EVALUATION OF THE EFFECT OF DENOSUMAB ON GIANT CELL TUMORS OF BONE AND A NEW GRADING SCHEME

ERDOĞAN K. E., DEVECİ M. A., PAYDAŞ S., GÖNLÜŞEN G.

POLISH JOURNAL OF PATHOLOGY , vol.67, no.4, pp.392-397, 2016 (SCI-Expanded, Scopus)

109. Does Preoperative Neutrophil To Lymphocyte Or Platelet To Lymphocyte Ratios Have A Role In Predicting Borderline Ovarian Tumors?

Khatib G., VARDAR M. A., GÜZEL A. B., Kucukgozgulec U., GÜMÜRDÜLÜ D., PAYDAŞ S.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.26, pp.32, 2016 (SCI-Expanded, Scopus)

110. Pulmonary sarcoidosis induced by the anti-PD-1 monoclonal antibody pembrolizumab or post-immunotherapy granulomatous reaction: which is more appropriate terminology?

ANNALS OF ONCOLOGY , vol.27, no.8, pp.1650-1651, 2016 (SCI-Expanded, Scopus)

111. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas

PAYDAŞ S., BAGIR E. K., DEVECİ M. A., GÖNLÜŞEN G.

MEDICAL ONCOLOGY , vol.33, no.8, 2016 (SCI-Expanded, Scopus) Sustainable Development

112. Management of hemopoietic neoplasias during pregnancy

Eskiyoruk I., KÜÇÜKGÖZ GÜLEÇ Ü., PAYDAŞ S., GÜZEL A. B., VARDAR M. A., BAĞIR KILIÇ E.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.104, pp.52-64, 2016 (SCI-Expanded, Scopus) Sustainable Development

113. Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study

ARTAÇ M., COŞKUN H. Ş., Korkmaz L., Kocer M., Turhal N. S., ENGİN H., et al.

CLINICAL GENITOURINARY CANCER , vol.14, no.4, 2016 (SCI-Expanded, Scopus)

114. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables

PAYDAŞ S., AÇIKALIN A., ERGİN M., Celik H., Yavuz B., Tanriverdi K.

MEDICAL ONCOLOGY , vol.33, no.4, 2016 (SCI-Expanded, Scopus)

115. Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study

Gunaldi M., Duman B. B., Afsar C. U., PAYDAŞ S., Erkisi M., KARA İ. O., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , vol.22, no.2, pp.242-247, 2016 (SCI-Expanded, Scopus) Sustainable Development

116. Acetabular Metstasis as Initial Presentation of Endometrial Cancer

khatib G., CÖMERT E., KÜÇÜKGÖZ GÜLEÇ Ü., GÜZEL A. B., VARDAR M. A., bağır E., et al.

türkiye klinikleri j case rep , vol.26, no.1, pp.27-9, 2016 (TRDizin) Sustainable Development

117. Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

PAYDAŞ S., OĞUL A., Irili C., GÖKÇAY S.

ANNALS OF HEMATOLOGY , vol.95, no.1, pp.145-146, 2016 (SCI-Expanded, Scopus)

118. The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma

Gulec U. K., PAYDAŞ S., GÜZEL A. B., VARDAR M. A., Khatib G., GÜMÜRDÜLÜ D.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.292, no.4, pp.923-929, 2015 (SCI-Expanded, Scopus)

119. CARCINOSARCOMA OF THE UTERUS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS OF THE MANAGEMENT AND OUTCOME

Gulec U. K., PAYDAŞ S., GÜMÜRDÜLÜ D., GÜZEL A. B., VARDAR M. A.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.25, no.9, pp.1092, 2015 (SCI-Expanded, Scopus)

120. Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma

PAYDAŞ S., Bagir E., SEYDAOĞLU G., Ercolak V., ERGİN M.

ANNALS OF HEMATOLOGY , vol.94, no.9, pp.1545-1552, 2015 (SCI-Expanded, Scopus) Sustainable Development

121. Primitive uterine neuroectodermal tumours: Two case reports

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY , vol.12, no.3, pp.185-187, 2015 (ESCI, Scopus, TRDizin)

122. Nine weeks versus 1 year adjuvant trastuzumab in patients with early breast cancer: an observational study by the Turkish Oncology Group (TOG)

İÇLİ F., Altundag K., AKBULUT H., PAYDAŞ S., Basaran G., Saip P., et al.

BREAST CANCER , vol.22, no.5, pp.480-485, 2015 (SCI-Expanded, Scopus) Sustainable Development

123. Helicobacter pylori eradication in gastric diffuse large B cell lymphoma

WORLD JOURNAL OF GASTROENTEROLOGY , vol.21, no.13, pp.3773-3776, 2015 (SCI-Expanded, Scopus)

124. Retrospective Analysis of 119 Osteosarcomas in a Single Centre Experience

GÜNALDI M., DUMAN B. B., Ercolak V., Afsar C. U., PAYDAŞ S., ERKISI M., et al.

JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE , vol.6, pp.117-120, 2015 (ESCI, TRDizin)

125. Hepatitis C virus and lymphoma

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.93, no.3, pp.246-256, 2015 (SCI-Expanded, Scopus) Sustainable Development

126. Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey

Salihoglu A., Elverdi T., KARADOGAN I., PAYDAŞ S., ÖZDEMİR E. R., ERDEM G., et al.

ANNALS OF HEMATOLOGY , vol.94, no.3, pp.415-420, 2015 (SCI-Expanded, Scopus)

127. DNA repair gene polymorphisms in B cell non-Hodgkin's lymphoma

BAHCECI A., PAYDAŞ S., Tanriverdi K., ERGİN M., SEYDAOĞLU G., UCAR G.

TUMOR BIOLOGY , vol.36, no.3, pp.2155-2161, 2015 (SCI-Expanded, Scopus) Sustainable Development

128. Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in early and advanced stage of squamous cell carcinoma of the lung

Afsar C. U., ŞAHİN B., GÜNALDI M., BAGIR E. K., GÜMÜRDÜLÜ D., BURGUT R., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY , vol.8, no.9, pp.9760-9771, 2015 (SCI-Expanded, Scopus) Sustainable Development

129. Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers

Karaca F., Afsar C. U., Gunaldi M., Erkurt E., Ercolak V., SERTDEMİR Y., et al.

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE , vol.8, no.1, pp.876-882, 2015 (SCI-Expanded, Scopus) Sustainable Development

130. THE EFFECT OF CHEMORADIOTHERAPY ON SURVIVAL IN LOCALLY ADVANCED UNRESECTABLE NON-SMALL CELL LUNG CANCER PATIENTS: EXPERIENCE FROM THE SOUTHEAST REGION OF TURKEY

Afsar C. U., Karaca F., Gunaldi M., KARA İ. O., Erkisi M., ŞAHİN B., et al.

ACTA MEDICA MEDITERRANEA , vol.31, no.4, pp.883-888, 2015 (SCI-Expanded, Scopus) Sustainable Development

131. PRAME Expression and Its Clinical Relevance in Hodgkin's Lymphoma

ERCOLAK V., PAYDAŞ S., BAGIR E., ERGİN M., SEYDAOĞLU G., CELIK H., et al.

ACTA HAEMATOLOGICA , vol.134, no.4, pp.199-207, 2015 (SCI-Expanded, Scopus) Sustainable Development

132. Using Pazopanib and Radiotherapy to Treat Metastatic Renal Cell Carcinoma with Acrometastases

USUL AFŞAR Ç., PAYDAŞ S.

International Journal of Medical and PharmaceuticalCase Reports , 2015 (Peer-Reviewed Journal)

133. The role of gender in patients with diffuse large B cell lymphoma treated with rituximab-containing regimens: a meta-analysis

Yildirim M., KAYA V., DEMIRPENCE O., PAYDAŞ S.

ARCHIVES OF MEDICAL SCIENCE , vol.11, no.4, pp.708-714, 2015 (SCI-Expanded, Scopus)

134. A Unique Case of Merkel Cell Carcinoma with Ovarian Metastasis

AÇIKALIN A., PAYDAŞ S., Gulec U. K., Uguz A., GÜMÜRDÜLÜ D.

BALKAN MEDICAL JOURNAL , vol.31, no.4, pp.356-359, 2014 (SCI-Expanded, Scopus, TRDizin)

135. Abdominal actinomycosis with multiple myeloma: A case report

Ercolak V., PAYDAŞ S., ERGİN M., Ates B. T., Duman B. B., Gunaldi M., et al.

ONCOLOGY LETTERS , vol.8, no.4, pp.1876-1878, 2014 (SCI-Expanded, Scopus)

136. Extramedullary Myeloid Tumor Involving the Pancreas: A Case Report and Review of the Literature

PAYDAŞ S., Ozdogu H., Gunaldi M., Haksoyler V., AÇIKALIN A., ERGİN M.

TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.3, pp.295-300, 2014 (SCI-Expanded, Scopus, TRDizin)

137. The Role of Radiotherapy Among the Therapeutic Options for Castleman's Disease

Karaca F., Afsar C. U., Erkurt E., ARSLANTAŞ H. S., Calis E., Ates B. T., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.31, no.2, pp.197-198, 2014 (SCI-Expanded, Scopus, TRDizin)

138. Prognostic importance of survivin, Ki-67, and topoisomerase II alpha in ovarian carcinoma

Gulec U. K., GÜMÜRDÜLÜ D., GÜZEL A. B., PAYDAŞ S., SEYDAOĞLU G., AÇIKALIN A., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.289, no.2, pp.393-398, 2014 (SCI-Expanded, Scopus) Sustainable Development

139. Dasatinib, large granular lymphocytosis, and pleural effusion: Useful or adverse effect?

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.89, no.2, pp.242-247, 2014 (SCI-Expanded, Scopus)

140. Pancreatic Carcinoma, Thrombosis and Mean Platelet Volume: Single Center Experience from the Southeast Region of Turkey

Afsar C. U., Gunaldi M., KUM P., Sahin B., Erkisi M., Kara I. O., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.21, pp.9143-9146, 2014 (SCI-Expanded, Scopus)

141. Evaluation of Endometrial Thickness and Bone Mineral Density Based on CYP2D6 Polymorphisms in Turkish Breast Cancer Patients Receiving Tamoxifen Treatment

Gunaldi M., Erkisi M., Afsar C. U., Ercolak V., PAYDAŞ S., KARA İ. O., et al.

PHARMACOLOGY , vol.94, pp.183-189, 2014 (SCI-Expanded, Scopus) Sustainable Development

142. Evaluation of CYP2D6 Polymorphic Types and Their Effect on Tamoxifen Efficacy Among Turkish Tamoxifen Users with Breast Cancer

Gunaldi M., Erkisi M., Afsar C., Ercolak V., Duman B., PAYDAŞ S., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.24, no.3, pp.157-162, 2014 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

143. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients

ŞAHİN F., SAYDAM G., Comert M., Uz B., Yavuz A. S., Turan E., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.4, pp.351-358, 2013 (SCI-Expanded, Scopus, TRDizin)

144. Sweet Syndrome in a Patient with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Curious Lymphocyte/Neutrophil Fluctuations

Afsar C. U., PAYDAŞ S., günaldı M., Duman B. B., erçolak V., ZORLUDEMİR S., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.4, pp.413-415, 2013 (SCI-Expanded, Scopus, TRDizin)

145. Coexistence of tuberous sclerosis complex and malignant melanoma

günaldı M., PAYDAŞ S., Afsar C. U., DORAN F.

SINGAPORE MEDICAL JOURNAL , vol.54, no.11, 2013 (SCI-Expanded, Scopus)

146. PROGNOSTIC IMPORTANCE OF SURVIVIN, KI-67, AND TOPOISOMERASE IIALPHA IN OVARIAN CARCINOMA

Gulec U. K., Guzel A., Gumurdulu D., Paydas S., Altintas A., Vardar M.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.23, no.8, 2013 (SCI-Expanded, Scopus)

147. Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers

PAYDAŞ S., PAYDAŞ S., BALAL M., AÇIKALIN A., ERGİN M., GÜRKAN E., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.3, pp.315-320, 2013 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

148. The Permanent Improvement of Proteinuria and Renal Failure With Colchicine and Enalapril in a Leukemic Patient With Renal Amyloidosis Secondary to Ankylosing Spondylitis: A Review of the Literature

PAYDAŞ S., PAYDAŞ S., BALAL M.

AMERICAN JOURNAL OF THERAPEUTICS , vol.20, no.4, pp.344-346, 2013 (SCI-Expanded, Scopus) Sustainable Development

149. A Case with Hypothyrodism Following Autologous Stem Cell Transplantation

Duman B. B., PAYDAŞ S., EVRAN M.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.2, pp.221-222, 2013 (SCI-Expanded, Scopus, TRDizin)

150. Sweet's syndrome: A revisit for hematologists and oncologists

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , vol.86, no.1, pp.85-95, 2013 (SCI-Expanded, Scopus) Sustainable Development

151. Carbamazepine and Multiple Myeloma: Possible Interaction

günaldı M., PAYDAŞ S., Afsar C. U., Duman B. B., erçolak V., Haksoyler V.

TURKISH JOURNAL OF HEMATOLOGY , vol.30, no.1, pp.83-84, 2013 (SCI-Expanded, Scopus, TRDizin)

152. Social Support and Hopelessness in Patients with Breast Cancer

Öztunç G., Yesil P., Paydaş S., Erdogan S.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.1, pp.571-578, 2013 (SCI-Expanded)

153. Energy drinks and chemotherapy: Can these products cause detrimental effects in cancer patients receiving chemotherapy?

PAYDAŞ S., sonay Y., avcı A., Duman B. B., Tumkaya E.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.24, no.1, 2013 (SCI-Expanded, Scopus) Sustainable Development

154. Nephrotic syndrome preceding multiple myeloma: Case report Nefrotik sendroma öncelik eden multipl miyeloma

PAYDAŞ S., KAYA B., PAYDAŞ S., GÖNLÜŞEN G., BALAL M.

Turkiye Klinikleri Journal of Medical Sciences , vol.33, no.2, pp.591-595, 2013 (SCI-Expanded, Scopus)

155. Comparative analysis of CA 125, ferritin, beta-2 microglobulin, lactic dehydrogenase levels in serum and peritoneal fluid in patients with ovarian neoplasia

Gulec U. K., PAYDAŞ S., GÜZEL A. B., BÜYÜKKURT S., SEYDAOĞLU G., VARDAR M. A.

MEDICAL ONCOLOGY , vol.29, no.4, pp.2937-2943, 2012 (SCI-Expanded, Scopus) Sustainable Development

156. Strong cross-talk between angiogenesis and EBV: do we need different treatment approaches in lymphoma cases with EBV and/or high angiogenic capacity

MEDICAL ONCOLOGY , vol.29, no.3, pp.2159-2165, 2012 (SCI-Expanded, Scopus)

157. Secondary malignancy after imatinib therapy: eight cases and review of the literature

Duman B. B., PAYDAŞ S., Disel U., Besen A., GÜRKAN E.

LEUKEMIA & LYMPHOMA , vol.53, no.9, pp.1706-1708, 2012 (SCI-Expanded, Scopus) Sustainable Development

158. Adenosine deaminase activity in patients with ovarian neoplasms

ÜRÜNSAK İ. F., Gulec U. K., PAYDAŞ S., SEYDAOĞLU G., GÜZEL A. B., VARDAR M. A.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , vol.286, no.1, pp.155-159, 2012 (SCI-Expanded, Scopus)

159. Preoperative evaluation, clinical characteristics, and prognostic factors of nongenital metastatic ovarian tumors: review of 48 patients

GÜZEL A. B., GULEC U. K., PAYDAŞ S., KHATİB G., GÜMÜRDÜLÜ D., VARDAR M. A., et al.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.33, no.5, pp.493-497, 2012 (SCI-Expanded, Scopus)

160. The Clinical Impact of Low Doses of Dasatinib in Patients with Chronic Myeloid Leukemia

AKSU S., ŞAHİN F., Uz B., YAVUZ S., Atay H., Kelkitli E., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.22, no.1, pp.8-14, 2012 (SCI-Expanded, Scopus, TRDizin)

161. Capecitabine-Induced Hypertriglyceridemia and Hyperglycemia: Two Cases

Duman B. B., PAYDAŞ S., Tetiker T., Gunaldi M., Afsar C. U., Ercolak V., et al.

PHARMACOLOGY , vol.90, pp.212-215, 2012 (SCI-Expanded, Scopus) Sustainable Development

162. Retrospective Analysis of 498 Primary Soft Tissue Sarcomas in a Single Turkish Centre

Duman B. B., Gunaldi M., Ercolak V., Afsar C. U., ŞAHİN B., Erkisi I. M. K., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.13, no.8, pp.4125-4128, 2012 (SCI-Expanded, Scopus)

163. Bendamustine and rituximab is effective and cost-effective in older cases with aggressive lymphomas?

PAYDAŞ S., Sargin O., GÖNLÜŞEN G.

ANNALS OF ONCOLOGY , vol.22, no.12, pp.2694-2695, 2011 (SCI-Expanded, Scopus)

164. Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib

PAYDAŞ S., Duman B. B., ERGİN M.

TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.3, pp.232-234, 2011 (SCI-Expanded, Scopus, TRDizin)

165. Short and long term effects of granulocyte colony-stimulating factor during induction therapy in acute myeloid leukemia patients younger than 65: Results of a randomized multicenter phase III trial

Beksac M., Ali R., Ozcelik T., Ozcan M., Ozcebe O., Bayik M., et al.

LEUKEMIA RESEARCH , vol.35, no.3, pp.340-345, 2011 (SCI-Expanded, Scopus)

166. PET CT imaging in extramedullary hematopoiesis and lung cancer surprise in a case with thalassemia intermedia

TURKISH JOURNAL OF HEMATOLOGY , vol.28, no.1, pp.60-62, 2011 (SCI-Expanded, Scopus, TRDizin) Sustainable Development

167. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far

Castillo J. J., Beltran B. E., Miranda R. N., PAYDAŞ S., Winer E. S., Butera J. N.

ONCOLOGIST , vol.16, no.1, pp.87-96, 2011 (SCI-Expanded, Scopus)

168. Hyponatremia Is Not a Rare Adverse Event in Bortezomib-Treated Patients

CHEMOTHERAPY , vol.57, no.5, pp.434-436, 2011 (SCI-Expanded, Scopus)

169. Smudge cells: Very old history and new conclusions

LEUKEMIA RESEARCH , vol.34, no.12, pp.1680, 2010 (SCI-Expanded, Scopus)

170. Hepatitis C virus and lymphoma: which is useful-serum or tissue?

JOURNAL OF CLINICAL PATHOLOGY , vol.63, no.11, pp.1040, 2010 (SCI-Expanded, Scopus) Sustainable Development

171. Right and left shifts for age in MDS

LEUKEMIA RESEARCH , vol.34, no.4, pp.409-410, 2010 (SCI-Expanded, Scopus)

172. Anti-angiogenic strategies will be a revolution in lymphoma?

LEUKEMIA RESEARCH , vol.34, no.4, pp.552, 2010 (SCI-Expanded, Scopus)

173. The value of F-18-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: diagnosis and follow-up

Yapar Z., Kibar M., Yapar A. F., Paydaş S., Reyhan M., Kara O., et al.

NUCLEAR MEDICINE COMMUNICATIONS , vol.31, pp.59-66, 2010 (SCI-Expanded, Scopus)

174. Stewart-Treves Syndrome: Questionable Response to Weekly Paclitaxel

PAYDAŞ S., Yapar Z., Gonlusen G.

CHEMOTHERAPY , vol.56, no.1, pp.66-68, 2010 (SCI-Expanded, Scopus)

175. Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab

Disel U., PAYDAŞ S., Yavuz S., Karakoc E.

CHEMOTHERAPY , vol.56, no.2, pp.89-93, 2010 (SCI-Expanded, Scopus)

176. Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature

PAYDAŞ S., ERGİN M., SEYDAOĞLU G., ERDOĞAN Ş., Yavuz S.

LEUKEMIA RESEARCH , vol.33, no.12, pp.1627-1635, 2009 (SCI-Expanded, Scopus)

177. Richter's Transformation; the Cause of Fever of Unknown Origin in a Case with Chronic Lymphocytic Leukemia

KURTARAN B., PAYDAŞ S., Yavuz S., Candevir A.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.19, no.3, pp.180-183, 2009 (SCI-Expanded, Scopus, TRDizin)

178. Antioxidant enzyme levels in cases with gastrointesinal cancer

Kekec Y., PAYDAŞ S., Tuli A., Zorludemir S., Sakman G., Seydaoglu G.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.20, no.4, pp.403-406, 2009 (SCI-Expanded, Scopus) Sustainable Development

179. Disseminated herpes zoster infection in a patient with lymphoma

KURTARAN B., PAYDAŞ S., Candevir A., Komur S., Aksu H. S. Z.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.39, no.3, pp.479-482, 2009 (SCI-Expanded, Scopus, TRDizin)

180. Castleman-like reaction due to toxic substance ingestion

PAYDAŞ S., Ergin M., Sikgenc M., Bicakci K., Kiroglu M.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.20, no.3, pp.328-330, 2009 (SCI-Expanded, Scopus)

181. Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?

LEUKEMIA RESEARCH , vol.33, no.4, pp.566-567, 2009 (SCI-Expanded, Scopus)

182. Efficacy of pneumatic compression and low-level laser therapy in the treatment of postmastectomy lymphoedema: a randomized controlled trial

Kozanoglu E., BAŞARAN S., PAYDAŞ S., SARPEL T.

CLINICAL REHABILITATION , vol.23, no.2, pp.117-124, 2009 (SCI-Expanded, Scopus)

183. The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas

PAYDAŞ S., SEYDAOĞLU G., ERGİN M., ERDOĞAN Ş., Yavuz S.

LEUKEMIA & LYMPHOMA , vol.50, no.3, pp.366-373, 2009 (SCI-Expanded, Scopus)

184. Dramatic response with capecitabine after cranial radiation to the brain parenchymal and leptomeningeal metastases from lung cancer

PAYDAŞ S., Bicakci K., Yavuz S.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.20, no.1, pp.96-99, 2009 (SCI-Expanded, Scopus) Sustainable Development

185. Is everything known in all faces of iceberg in PRAME?

LEUKEMIA RESEARCH , vol.32, no.9, pp.1356-1357, 2008 (SCI-Expanded, Scopus)

186. Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas

PAYDAŞ S., ERGİN M., ERDOĞAN Ş., SEYDAOĞLU G.

LEUKEMIA RESEARCH , vol.32, no.9, pp.1424-1430, 2008 (SCI-Expanded, Scopus)

187. ANTİ-CD20 ANTİKOR-RİTUKSİMAB VE İNFEKSİYON İLİŞKİSİ: BİR OLGU NEDENİYLE

KURTARAN B., PAYDAŞ S., ULU A., Yavuz S., İNAL A. S.

ANKEM Dergisi , vol.22, no.3, pp.156-159, 2008 (TRDizin)

188. Motor neuron disease associated with multiple myeloma

Koc F., Paydas S., Yerdelen D., Demirkiran M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.118, no.3, pp.337-341, 2008 (SCI-Expanded, Scopus)

189. Thrombospondin-1 (TSP-1) and Survivin (S) expression in non-Hogkin's lymphomas

PAYDAŞ S., ERGİN M., ERDOĞAN Ş., SEYDAOĞLU G., Yavuz S., Disel U.

LEUKEMIA RESEARCH , vol.32, no.2, pp.243-250, 2008 (SCI-Expanded, Scopus) Sustainable Development

190. Anti CD20 antikor rituksimab ve infeksiyon ilişkisi bir olgu nedeniyle

KURTARAN B., CANDEVİR A., PAYDAŞ S., İNAL A. S., YAVUZ S.

ANKEM DERGİSİ , vol.22, no.3, pp.156-159, 2008 (TRDizin)

191. Tailored thromboprophylaxis for patients with multiple myeloma treated by IMIDs

LEUKEMIA & LYMPHOMA , vol.49, no.8, pp.1644-1645, 2008 (SCI-Expanded, Scopus)

192. Survivin and EPR-1 expression in acute leukemias: Prognostic significance and review of the literature

Oto O. A., Paydas S., Tanriverdi K., Seydaoglu G., Yavuz S., Disel U.

LEUKEMIA RESEARCH , vol.31, no.11, pp.1495-1501, 2007 (SCI-Expanded, Scopus)

193. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature

Paydas S., Tanriverdi K., Yavuz S., Seydaoglu G.

LEUKEMIA RESEARCH , vol.31, no.3, pp.365-369, 2007 (SCI-Expanded, Scopus)

194. Amphotericin B deoxycholate (d-AMB) use in cases with febrile neutropenia and fungal infections: lower toxicity with suitable premedication

Oto O. A., Paydas S., Disel U., Yavuz S., Seydaoglu G.

MYCOSES , vol.50, no.2, pp.135-139, 2007 (SCI-Expanded, Scopus)

195. Cyclooxygenase-2 expression in non-Hodgkin's lymphomas

Paydas S., Ergin M., Erdogan S., Seydaoglu G.

LEUKEMIA & LYMPHOMA , vol.48, no.2, pp.389-395, 2007 (SCI-Expanded, Scopus)

196. Gravin gene expression in acute leukaemias: Clinical importance and review of the literature

Yildirim M., Paydas S., Tanriverdi K., Seydaoglu G., Disel U., Yavuz S.

LEUKEMIA & LYMPHOMA , vol.48, no.6, pp.1167-1172, 2007 (SCI-Expanded, Scopus) Sustainable Development

197. Granulocytic sarcoma: 32 cases and review of the literature

Paydas S., Zorludemir S., Ergin M.

LEUKEMIA & LYMPHOMA , vol.47, no.12, pp.2527-2541, 2006 (SCI-Expanded, Scopus)

198. Can survivin expression predict the response to bortezomib in cases with mantle cell lymphoma?

LEUKEMIA & LYMPHOMA , vol.47, no.11, pp.2412-2413, 2006 (SCI-Expanded, Scopus)

199. Dramatic Improvement of Pulmonary Mucormycosis After Surgery in a Case Without Immunodeficiency

POYRAZOĞLU H. H., PAYDAŞ S., UĞUZ A. H., ERKEN E., Yıldırım F., PAYDAŞ S., et al.

INFECTIOUS DISEASES IN CLINICAL PRACTICE , vol.14, no.6, pp.403-405, 2006 (Scopus)

200. Transfusion-associated graft-versus-host disease

OTO O. A., Paydas S., Baslamisli F., TUNCER I., Ergin M., Kalakoc E., et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE , vol.17, no.3, pp.151-156, 2006 (SCI-Expanded, Scopus) Sustainable Development

201. Young age MDS: Differences between Western and Eastern countries

LEUKEMIA RESEARCH , vol.30, no.3, pp.362, 2006 (SCI-Expanded, Scopus)

202. Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia

DISEL U., Paydas S., Yavuz S., TUNCER I., Alpay R.

LEUKEMIA RESEARCH , vol.30, no.3, pp.364, 2006 (SCI-Expanded, Scopus)

203. Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases

Paydas S., Yavuz S., Disel U.

ANNALS OF HEMATOLOGY , vol.85, no.1, pp.63, 2006 (SCI-Expanded, Scopus)

204. PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects

Paydas S., Tanriverdi K., Yavuz S., Disel U., Baslamisli F., Burgut R.

AMERICAN JOURNAL OF HEMATOLOGY , vol.79, no.4, pp.257-261, 2005 (SCI-Expanded, Scopus)

205. Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation

BONE MARROW TRANSPLANTATION , vol.36, no.3, pp.277, 2005 (SCI-Expanded, Scopus)

206. VEGF-C expression in breast cancer: Clinical importance

Yavuz S., Paydas S., Disel U., Zorludemir S., Erdogan Ş.

ADVANCES IN THERAPY , vol.22, no.4, pp.368-380, 2005 (SCI-Expanded, Scopus) Sustainable Development

207. Granulocytic sarcoma of the heart: Extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone

Kara I., Sahin B., Paydas S., Kara B.

LEUKEMIA & LYMPHOMA , vol.46, no.7, pp.1081-1084, 2005 (SCI-Expanded, Scopus)

208. Different glomerulopathies accompanying non-small-cell lung cancer

Paydas S., SOYDAS B., Paydas S., BALAL M., ERDOGAN Ş., TUNCER I.

MOUNT SINAI JOURNAL OF MEDICINE , vol.72, no.4, pp.279-281, 2005 (SCI-Expanded, Scopus) Sustainable Development

209. Bilateral choroidal infilltration from indolent non-Hodgkin's lymphoma: A rapid course with poor prognosis

Ozcan A. A., Paydas S., Soylu M., Yavuz S.

LEUKEMIA & LYMPHOMA , vol.46, no.4, pp.615-617, 2005 (SCI-Expanded, Scopus)

210. Post transplant lymphoproliferative disease: detection of tumor by Tc99m sestaMIBI and treatment with rituximab.

Paydas S., Yapar Z., Ergin M., Guney İ. B., Disel U., Yavuz S.

Bone marrow transplantation , vol.35, no.3, pp.317-8, 2005 (SCI-Expanded, Scopus)

211. Hepatitis C virus infection and lymphomas

INTERNATIONAL JOURNAL OF CANCER , vol.113, no.2, pp.338, 2005 (SCI-Expanded, Scopus) Sustainable Development

212. Bıçakcı, Ş., Aslan K., Bozdemir H., Paydaş S., ve Sarıca Y., ?Kronik Lenfositik Lösemi ve Santral Sinir Sistemi Tutulumu,?

BIÇAKCI Ş., BOZDEMİR H., ASLAN K., PAYDAŞ S., SARICA Y.

TÜRK NÖROLOJİ DERGİSİ , vol.11, pp.411-414, 2005 (ESCI, Scopus, TRDizin)

213. Glomerular disease in patients with malignant disease: Four cases and review of literature

Paydas S., BALAL M., Paydas S., OTO O., GONLUSEN G.

RENAL FAILURE , vol.27, no.1, pp.1-6, 2005 (SCI-Expanded, Scopus)

214. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients

Kara I., Sahin B., Paydas S., Cetiner S.

SAUDI MEDICAL JOURNAL , vol.25, no.11, pp.1587-1592, 2004 (SCI-Expanded)

215. Scrotal ulceration associated with ATRA

AMERICAN JOURNAL OF HEMATOLOGY , vol.77, no.2, pp.206-207, 2004 (SCI-Expanded, Scopus)

216. Detection of hepatitis C virus RNA in paraffin-embedded tissues from patients with non-Hodgkin's lymphoma

Paydas S., Ergin M., Tanriverdi K., Yavuz S., Disel U., Kilic N., et al.

AMERICAN JOURNAL OF HEMATOLOGY , vol.76, no.3, pp.252-257, 2004 (SCI-Expanded, Scopus) Sustainable Development

217. Lymphadenopathy in adult-onset Still's disease mimicking peripheral T-cell lymphoma

Soy M., Ergin M., Paydas S.

CLINICAL RHEUMATOLOGY , vol.23, no.1, pp.81-82, 2004 (SCI-Expanded, Scopus)

218. Ovarian granulocytic sarcoma

Yavuz S., Paydas S., Disel U., Erdogan Ş.

LEUKEMIA & LYMPHOMA , vol.45, no.1, pp.183-185, 2004 (SCI-Expanded, Scopus)

219. VEGF-C expression in breast cancer

Yavuz S., PAYDAŞ S., ZORLUDEMİR S., Disel U., ŞAHİN B.

ANNALS OF ONCOLOGY , vol.15, pp.24, 2004 (SCI-Expanded, Scopus) Sustainable Development

220. Prostatic hypertrophy and prostatic infiltration in small lymphocytic lymphoma

Yavuz S., Paydas S., Disel U., Zorludemir S., Erdogan Ş.

LEUKEMIA & LYMPHOMA , vol.45, no.1, pp.201-202, 2004 (SCI-Expanded, Scopus)

221. Fludarabine as the possible cause of acute myelofibrosis

Paydas S., Disel U., Yavuz S., Ergin M.

HEMATOLOGY JOURNAL , vol.5, no.3, pp.283-284, 2004 (SCI-Expanded, Scopus)

222. Fludarabine-induced hemolytic anemia: successful treatment by rituximab

HEMATOLOGY JOURNAL , vol.5, no.1, pp.81-83, 2004 (SCI-Expanded, Scopus)

223. Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma

Hazar B., Paydas S., Zorludemir S., Sahin B., TUNCER I.

LEUKEMIA & LYMPHOMA , vol.44, no.12, pp.2089-2093, 2003 (SCI-Expanded, Scopus)

224. Successful rituximab therapy for hemolytic anemia associated with relapsed splenic marginal zone lymphoma with leukemic phase

Paydas S., Yavuz S., Disel U., Sahin B., Ergin M.

LEUKEMIA & LYMPHOMA , vol.44, no.12, pp.2165-2166, 2003 (SCI-Expanded, Scopus)

225. Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma

Paydas S., Kilic B., Yavuz S., Disel U., Tanriverdi K., Sahin B., et al.

AMERICAN JOURNAL OF HEMATOLOGY , vol.74, no.2, pp.89-93, 2003 (SCI-Expanded, Scopus) Sustainable Development

226. Hepatitis B virus reactivation during fludarabine therapy in non-Hodgkin's lymphoma

Yavuz S., Paydas S., Disel U., Sahin B.

LEUKEMIA & LYMPHOMA , vol.44, no.7, pp.1249-1250, 2003 (SCI-Expanded, Scopus) Sustainable Development

227. Survivin and aven: two distinct antiapoptotic signals in acute leukemias

Paydas S., Tanriverdi K., Yavuz S., Disel U., Sahin B., Burgut R.

ANNALS OF ONCOLOGY , vol.14, no.7, pp.1045-1050, 2003 (SCI-Expanded, Scopus)

228. Serous retinal detachment in a case with chronic lymphocytic leukemia: no response to systemic and local treatment

Paydas S., Soylu M., Disel U., Yavuz S., Sahin B., Ersoz C., et al.

LEUKEMIA RESEARCH , vol.27, no.6, pp.557-559, 2003 (SCI-Expanded, Scopus)

229. Mucormycosis of the tongue in a patient with acute lymphoblastic leukemia: A possible relation with use of a tongue depressor

Paydas S., Yavuz S., Disel U., Yildirim M., Besen A., Sahin B., et al.

AMERICAN JOURNAL OF MEDICINE , vol.114, no.7, pp.618-620, 2003 (SCI-Expanded, Scopus)

230. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia

Paydas S., Yavuz S., Disel U., Sahin B., Canbolat T., Tuncer İ.

LEUKEMIA & LYMPHOMA , vol.44, no.3, pp.547-548, 2003 (SCI-Expanded, Scopus)

231. Extramedullary relapse in the pleura in acute promyelocytic leukemia

Disel U., Yavuz S., Paydas S., Sahin B., Zeren H.

LEUKEMIA & LYMPHOMA , vol.44, no.1, pp.189-191, 2003 (SCI-Expanded, Scopus)

232. HCV and tumors of the immune system

LEUKEMIA RESEARCH , vol.26, no.12, pp.1141, 2002 (SCI-Expanded, Scopus)

233. Granulomatous reaction after chemotherapy for Hodgkin's disease

Paydas S., Yavuz S., Disel U., Zeren H., Hasturk S., HANTA I., et al.

LEUKEMIA RESEARCH , vol.26, no.10, pp.967-970, 2002 (SCI-Expanded, Scopus)

234. Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature

Paydas S., Ergin M., Baslamisli F., Yavuz S., Zorludemir S., Sahin B., et al.

AMERICAN JOURNAL OF HEMATOLOGY , vol.70, no.4, pp.300-305, 2002 (SCI-Expanded, Scopus) Sustainable Development

235. Sickle cell anemia and hematological neoplasias

LEUKEMIA & LYMPHOMA , vol.43, no.7, pp.1431-1434, 2002 (SCI-Expanded, Scopus)

236. Cutaneous lesions and chronic myelocytic leukemia (CML) in progression

ANNALS OF HEMATOLOGY , vol.81, no.3, pp.178, 2002 (SCI-Expanded, Scopus)

237. Vascular endothelial growth factor (VEGF) expression in plasmacytoma

Paydas S., Zorludemir S., Baslamisli F., TUNCER İ.

LEUKEMIA & LYMPHOMA , vol.43, no.1, pp.139-143, 2002 (SCI-Expanded, Scopus)

238. MUC1 expression in plasmacytoma

Paydas S., Sahin B., Gonlusen G., Hazar B., Zorludemir S.

LEUKEMIA RESEARCH , vol.25, no.3, pp.221-225, 2001 (SCI-Expanded, Scopus)

239. Vasculitis and leukemia

Paydas S., Zorludemir S., Sahin B.

LEUKEMIA & LYMPHOMA , vol.40, pp.105-113, 2000 (SCI-Expanded, Scopus)

240. Leukaemia cutis and leukaemic vasculitis

Paydas S., Zorludemir S.

BRITISH JOURNAL OF DERMATOLOGY , vol.143, no.4, pp.773-779, 2000 (SCI-Expanded, Scopus)

241. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy

Tasova Y., Sahin B., Koltas S., Paydas S.

ACTA MEDICA OKAYAMA , vol.54, no.3, pp.133-136, 2000 (SCI-Expanded, Scopus) Sustainable Development

242. The association of thyrotoxicosis and chronic lymphoproliferative disorders

Paydas S., Sahin B., Hazar B., Yavuz S.

LEUKEMIA & LYMPHOMA , vol.38, pp.131-135, 2000 (SCI-Expanded, Scopus)

243. Lymphomatous skin infiltration at the site of previous varicella zoster virus infection in a patient with T cell lymphoma

Paydas S., Sahin B., Yavuz S., TUNCER I., Gonlusen G.

LEUKEMIA & LYMPHOMA , vol.37, pp.229-234, 2000 (SCI-Expanded, Scopus)

244. Granulocytic sarcoma as the cause of giant abdominal mass: diagnosis by fine needle aspiration and review of the literature

Paydas S., Hazar B., Sahin B., Gonlusen G.

LEUKEMIA RESEARCH , vol.24, no.3, pp.267-269, 2000 (SCI-Expanded, Scopus)

245. Postmastectomy malignant lymphoma

Paydas S., Sahin B., Yavuz S., Gonlusen G.

LEUKEMIA & LYMPHOMA , vol.36, pp.417-421, 2000 (SCI-Expanded, Scopus)

246. Sweet's syndrome accompanying leukaemia: seven cases and review of the literature

Paydas S., Sahin B., Zorludemir S.

LEUKEMIA RESEARCH , vol.24, no.1, pp.83-86, 2000 (SCI-Expanded, Scopus)

247. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey

Paydas S., Kilic B., Sahin B., Bugdayci R.

BRITISH JOURNAL OF CANCER , vol.80, no.9, pp.1303-1305, 1999 (SCI-Expanded, Scopus) Sustainable Development

248. Interesting morphologic finding in T-cell acute lymphoblastic leukemia

YETİŞİR A. E., BÜYÜKŞİMŞEK M., TOHUMCUOĞLU M., PAYDAŞ S.

DIAGNOSTIC CYTOPATHOLOGY , vol.21, no.1, pp.55-56, 1999 (SCI-Expanded, Scopus)

249. All trans retinoic acid as the possible cause of necrotizing vasculitis

Paydas S., Sahin B., Zorludemir S., Hazar B.

LEUKEMIA RESEARCH , vol.22, no.7, pp.655-657, 1998 (SCI-Expanded, Scopus)

250. Bone marrow necrosis in antiphospholipid syndrome

Paydas S., Kocak R., Zorludemir S., Baslamisli F.

JOURNAL OF CLINICAL PATHOLOGY , vol.50, no.3, pp.261-262, 1997 (SCI-Expanded, Scopus)

251. p53 protein expression in gastrointestinal lymphomas

Hazar B., Paydas S., Zorludemir S., Sahin B., TUNCER I.

ONCOLOGY , vol.54, no.1, pp.84-87, 1997 (SCI-Expanded, Scopus)

252. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis

Sahin B., Paydas S., Cosar E., Bicakci K., Hazar B.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES , vol.15, no.11, pp.866-869, 1996 (SCI-Expanded, Scopus)

253. Malignant lymphoma with severe hypoglycaemia

Camci C., Paydas S., Sahin B., Cosar E.

EUROPEAN JOURNAL OF CANCER , no.12, pp.2185, 1996 (SCI-Expanded, Scopus)

254. Younger age observation in myelodysplastic syndrome

Paydas S., KOCAK R.

LEUKEMIA RESEARCH , vol.20, no.4, pp.367, 1996 (SCI-Expanded, Scopus)

255. INTRACELLULAR GLUTATHIONE CONTENT IN LEUKEMIAS

PAYDAS S., YUREGIR G., SAHIN B., SEYREK E., BURGUT R.

ONCOLOGY , vol.52, no.2, pp.112-115, 1995 (SCI-Expanded, Scopus)

256. P53 PROTEIN EXPRESSION IN LEUKEMIAS

PAYDAS S.

ACTA ONCOLOGICA , vol.34, no.1, pp.23-26, 1995 (SCI-Expanded, Scopus)

257. FLOW CYTOMETRIC DNA ANALYSIS IN PRIMARY GASTROINTESTINAL LYMPHOMA

PAYDAS S., DINCOL D., GILMANSACHS A., TUNCER İ., ZORLUDEMIR S., ERSOZ C., et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH , vol.13, no.3, pp.229-232, 1994 (SCI-Expanded, Scopus)

258. SERUM LEVELS OF TUMOR-NECROSIS-FACTOR IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK

SOYLU L., OZCAN C., CETIK F., PAYDAS S., KIROGLU M. M., AYDOGAN B., et al.

AMERICAN JOURNAL OF OTOLARYNGOLOGY , vol.15, no.4, pp.281-285, 1994 (SCI-Expanded, Scopus)

259. DNA-PLOIDY, PROLIFERATIVE ACTIVITY, AND CONCANAVALIN-A REACTIVITY IN BREAST-CANCER

PAYDAS S., SARPEL S., GILMANSACHS A., TUNCER I., PEHLIVAN S., TUNALI N., et al.

JOURNAL OF SURGICAL ONCOLOGY , vol.56, no.1, pp.21-24, 1994 (SCI-Expanded, Scopus) Sustainable Development

260. Mide ve Kolorektal Kanserli Hastalarda Serum CA 72-4 ve CEA Değerlerinin Karşılaştırılması

Kibar M., Sargın Ö., Paydaş S.

ÇUKUROVA ÜNİVERSİTESİ EĞİTİM FAKÜLTESİ DERGİSİ , vol.18, pp.251-259, 1993 (ESCI, TRDizin) Sustainable Development

261. Concentrations of Trace Elements In 190 Patients With Various Malignancies.

KEKEÇ M. Y., PAYDAŞ S., SÖNMEZ H., Yavuz A., BAŞLAMIŞLI İ. F., Yüreğir G., et al.

Anca Oncolojica Turcica , vol.26, pp.9-14, 1993 (Peer-Reviewed Journal)

262. İnterferon ve İntraperitoneal Uyfulanması

KEKEÇ M. Y., PAYDAŞ S., Altaca G.

Çukurova Üniversitesi Tıp Fakültesi Arşiv Dergisi , vol.2, pp.215-222, 1993 (Peer-Reviewed Journal)

263. COEXISTENCE OF DIABETES-INSIPIDUS AND IDIOPATHIC THROMBOCYTOPENIC PURPURA

PAYDAS S., PAYDAS S.

INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.56, no.1, pp.103-105, 1992 (SCI-Expanded, Scopus) Sustainable Development

264. PERNICIOUS-ANEMIA IN TURKEY

KOCAK R., PAYDAS S.

INTERNATIONAL JOURNAL OF HEMATOLOGY , vol.55, no.2, pp.117-119, 1992 (SCI-Expanded, Scopus) Sustainable Development

265. FERRITIN LEVELS IN MALIGNANT EFFUSIONS - A USEFUL MARKER

PAYDAS S., SARGIN O., OZBEK S., GURBUZ E.

EUROPEAN JOURNAL OF CANCER , vol.26, no.8, pp.919, 1990 (SCI-Expanded, Scopus)

266. NON-HODGKINS LYMPHOMAS IN TURKEY

SARPEL S., PAYDAS S., TUNCER I., VARINLI S., KOKSAL M., AKOGLU T.

CANCER , vol.62, no.8, pp.1653-1657, 1988 (SCI-Expanded, Scopus)

267. INCOMPLETE BEHCETS-SYNDROME WITH UNUSUAL MANIFESTATIONS

AKOGLU T., PAYDAS S., SARPEL S., TUNALI N., TUNCER I.

ANNALS OF THE RHEUMATIC DISEASES , vol.46, no.8, pp.632-633, 1987 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 113

1. 736 Molecular classification and clinical significance in recurrent endometrial adenocarcinomas

KÜÇÜKGÖZ GÜLEÇ Ü., PAYDAŞ S., KILIÇ BAĞIR E., AKBAL E., KÜÇÜKBİNGÖZ E., KHATİB G., et al.

İnternational Journal of Gynecologic Cancer, 10 March 2024, (Summary Text)

2. THE CUKUROVA SCORE IN THE PREDICTION OF PRIMARY CYTOREDUCTION IN OVARIAN CANCER: A PRELIMINARY STUDY

KHATIB G., SEYFETTİNOĞLU S., KÖSE S., KÜÇÜKGÖZ GÜLEÇ Ü., AVCI A., GÜZEL A. B., et al.

ESGO 2023 Istanbul: 24th European Gynaecological Oncology Congress, İstanbul, Turkey, 28 September - 01 October 2023, (Summary Text)

3. CLINICAL SIGNIFICANCE OF HER2/NEU, MUC1, ESTROGEN AND PROGESTERONE RECEPTOR EXPRESSION IN MALIGNANT EPITHELIAL OVARIAN TUMORS

ÇATALDEĞİRMEN A., KÜÇÜKGÖZ GÜLEÇ Ü., GÜZEL A. B., KHATIB G., PAYDAŞ S., KILIÇ BAĞIR E., et al.

23. ESGO, Germany, 27 October 2022, (Full Text)

4. ORTA-YÜKSEK RİSKLİ EMETOJENİK KEMOTERAPİ ALAN HASTALARDA FOSEPREPİTANT KULLANIMI:RETROSPEKTİF ANKET ÇALIŞMASI

MİRİLİ C., KUMAŞ G., KURT Z., ALTINKAYA M., PAYDAŞ S.

9. Türk Tıbbi Onkoloji Kongresi, Girne, Cyprus (Kktc), 18 May 2022, (Summary Text)

5. İNDOLENT NON-HODGKİN LENFOMA HASTALARINDA EZH-2 İFADESİNİN PROGNOZ ÜZERİNDE ETKİSİ

ŞENER M., KILIÇ BAĞIR E., DİNÇYÜREK H. D., SEYDAOĞLU G., PAYDAŞ S., GÜRKAN E.

46. Ulusal Hematoloji Kongresi/sanal kongre, Turkey, 28 - 31 October 2020, pp.90-91, (Full Text)

6. Clinical significance of c-MYC/EZH-2 expression and Merlin loss

Arslan A. M., Paydas S., Gumurdulu D., Bagir E., Mirili C.

32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, ELECTR NETWORK, 24 - 25 October 2020, vol.138, (Summary Text)

7. Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey

Demirci U., GÖKMEN E., Eralp Y., Gunduz S., SEZGİN GÖKSU S., KORKMAZ T., et al.

San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2019, vol.80, (Summary Text) Sustainable Development

8. Correlation of PET-CT and Bone Marrow Biopsy Results to Evaluate Bone Marrow Infiltration in HL Case Series

3. Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey, 30 October - 03 November 2019, (Summary Text)

9. Clinical Significance of PRAME and PDL-1 Expression in Colon Cancer

OĞUL A., PAYDAŞ S., DORAN F., EREN ATEŞ K., TOHUMCUOĞLU M., BÜYÜKŞİMŞEK M., et al.

3. Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey, 30 October - 03 November 2019, (Summary Text) Sustainable Development

10. A CLINICOPATHOLOGIC CHARACTERISTICS AND PROGNOSIS COMPARISON BETWEEN UTERINE CARCINOSARCOMAS AND UTERINE HIGH GRADE ENDOMETRIAL CARCINOMAS

KÜÇÜKGÖZ GÜLEÇ Ü., PAYDAŞ S., GÜZEL A. B., KILIÇ BAĞIR E., KHATİB G., VARDAR M. A.

ESGO 2019 congress, 02 January 2020 - 05 November 2019, (Full Text)

11. Long-term Results of Brentuximab Vedotin in Relapsed and Refractory Hodgkin Lymphoma: Multi-center Real-life Experience

FERHANOĞLU A. B., ÖZBALAK M. M., Salihoğlu A., SOYSAL T., Karadogan İ., PAYDAŞ S., et al.

6th Aegean Hematology Oncology Symposium, 3 - 06 October 2019, (Summary Text)

12. Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable = Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey

BEKSAÇ M., CENGİZ SEVAL G., PAYDAŞ S., TUĞLULAR A. T., ARSLAN Ö., GÖKER A. H., et al.

17th International Myeloma Workshop, 12 - 15 September 2019, (Summary Text)

13. NHL OLGULARINDA TANI ANINDA PET-CT, KEMİK İLİĞİ İNFİLTRASYONUNU SAPTAMADA KEMIK İLİĞİ BİYOPSİSİNİN YERİNİ ALABİLİR Mİ?

Kolsuz İ., Büyükşimşek M., Yetişir A. E., Paydaş S., Güney İ. B.

23. Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 21 April 2019, (Summary Text)

14. AGRESİF LENFOMADA DA-R-EPOCH TEDAVİ SONUÇLARIMIZ

YETİŞİR A. E., PAYDAŞ S., BÜYÜKŞİMŞEK M., TOHUMCUOĞLU M.

23. ULUSAL KANSER KONGRESİ, Turkey, 17 - 21 April 2019, (Summary Text)

15. LORLATINIB EXPERIENCE IN A CASE WITH NONSMALL CELL LUNG CANCER (NSCLC): HIGH EFFICACY BUT UNEXPECTED HIGH TOXICITY

BÜYÜKŞİMŞEK M., PAYDAŞ S., YETİŞİR A. E., MİRİLİ C., OĞUL A., BAŞDOĞAN S.

23. Ulusal Kanser Kongresi, Turkey, 17 - 21 April 2019, (Summary Text) Sustainable Development

16. Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Isik U., Kostek O., Demiray G., Dirican A., Simsek M., Buyuksimsek M., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37, (Summary Text) Sustainable Development

17. Posttransplant lymphoproliferative disease (PTLPD)-Central nervous system (CNS) involvement in a case with liver transplantation: Case report and review of the literatüre

KAKCI M., PAYDAŞ S., ASARKAYA E., ZORLUDEMİR S., acikalin a., bagir E., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 03 May 2019, (Summary Text)

18. NHL OLGULARINDA TANI ANINDA PET-CT, KEMIKILIĞI INFILTRASYONUNU SAPTAMADA KEMIK ILIĞIBIYOPSISININ YERINI ALABILIR MI?

KOLSUZ İ., BÜYÜKŞİMŞEK M., Yetişir A. E., PAYDAŞ S., GÜNEY İ. B.

Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 21 April 2019, (Full Text)

19. Meme Kanserinde Neoadjuvan Kemoterapiye Yanıtın Öngörülmesinde İnflamatuar Belirteçlerin Önemi

BÜYÜKŞİMŞEK M., SÜMBÜL H. E., PAYDAŞ S.

2. Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey, 31 October - 04 November 2018, (Summary Text) Sustainable Development

20. Myeloma böbreği: 8 olguda klinikopatolojik değerlendirme

ALTUN DİNCELİR E., GÖNLÜŞEN G., PAYDAŞ S., KAYA B., ERDOĞAN K. E., PAYDAŞ S.

28. Ulusal Patoloji Kongresi, Turkey, 27 - 30 October 2018, (Summary Text)

21. NİVOLUMAB: 3. YIL ERKEN ERİŞİM PROGRAMIVERİLERİ

MİRİLİ C., PAYDAŞ S., GÜNEY İ. B.

VIII. Ulusal Akciğer Kanseri Kongresi, BODRUM, Turkey, 4 - 07 October 2018, (Summary Text)

22. Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.

KILIÇKAP S., Öztürk A., KARADURMUŞ N., KORKMAZ T., YUMUK P. F., ÇİÇİN İ., et al.

IASLC 19th World Conference On Lung Cancer, Canada, 23 - 26 September 2018, vol.13, pp.1020, (Full Text) Sustainable Development

23. PODOCYTURİA IN MULTİPLE MYELOMA PATİENTS HAS A TENDENCY TO İNCREASE WİTH TREATMENT

KUZU T., PAYDAŞ S., GÜRKAN E., PAYDAŞ S., UĞUZ A. H.

23 rd CONGRESS OF THE EUROPEAN HEMATOLOGY ASSOCİATİON, Stockholm, Sweden, 14 - 17 June 2018, pp.216, (Full Text)

24. Merkel cell carcinoma in Turkey: A multicentric study.

yıldız f., BÜYÜKŞİMŞEK M., sakalar t., AYDIN Ö., TURNA Z. H., babacan n., et al.

2018 ASCO Annual Meeting, 1 - 05 June 2018, (Full Text)

25. EGFR, MUC-1 and PD-L1 expressions in cases with triple negative breast cancer (TNBC)

MİRİLİ C., PAYDAŞ S., BAĞIR KILIÇ E., SEYDAOĞLU G., OĞUL A., BÜYÜKŞİMŞEK M., et al.

ASCO 2018, Chicago, United States Of America, 1 - 05 June 2018, (Summary Text) Sustainable Development

26. Son dönem böbrek yetmezliği ve Sistinozis:41 yaşında göz muayenesi ile tanı alabilen bir olgu sunumu.

DEMİR İ., Şeker-Yılmaz B., KILAVUZ S., KOR D., BULUT F. D., ERDEM E., et al.

VI. Uluslararası Katılımlı Lizozomal Hastalıklar Kongresi, Turkey, 11 - 15 April 2018, (Summary Text)

27. KEMOTERAPİ İLİŞKİLİ PELLAGRA

OĞUL A., PAYDAŞ S., MİRİLİ C., BÜYÜKŞİMŞEK M., yetişir a. e., TOHUMCUOĞLU M., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text)

28. EDİNSEL İMMÜN YETMEZLİKLİ BİR OLGUDA KAPOSİ SARKOMUNUNEŞLİK ETTİĞİ TAFRO SENDROMU

TOHUMCUOĞLU M., PAYDAŞ S., OĞUL A., BÜYÜKŞİMŞEK M., yetişir a. e., KURTARAN B., et al.

7. Türk Tıbbi Onkoloji Konresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text)

29. KÜÇÜK HÜCRELİ AKCİĞER KANSERİNDE (KHAK) NÖTROFİL LENFOSİT ORANI (NLO) İLE PET-CT’DE SAPTANAN METABOLİK PARAMETRELERİNİN (PET-CT MP) PROGNOSTİK ÖNEMİ VE NLO İLE PET-CT MP İLİŞKİSİ

MİRİLİ C., PAYDAŞ S., GÜNEY İ. B., SEYDAOĞLU G., KAPUKAYA T. K., OĞUL A., et al.

7.Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text) Sustainable Development

30. KEMOTERAPi iLiŞKİLİ PELLAGRA

OĞUL A., PAYDAŞ S., MİRİLİ C., BÜYÜKŞİMŞEK M., YETİŞİR A. E., TOHUMCUOĞLU M., et al.

7. Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018, (Summary Text)

31. NIVOLUMAB ERKEN ERIŞIM PROGRAMI: UZUN DÖNEM TAKIPVERILERI

Mirili C., Paydaş S., Güney İ. B., Oğul A., Gökçay S., Büyükşimşek M., et al.

7. Türk Tıbbi Onkoloji Kongresi, Antalya, Turkey, 21 - 25 March 2018, (Summary Text)

32. EDİNSEL İMMÜN YETMEZLİKLİ BİR OLGUDA KAPOSİ SARKOMUNUN EŞLİK ETTİĞIİTAFRO SENDROMU

TOHUMCUOĞLU M., PAYDAŞ S., OĞUL A., BÜYÜKŞİMŞEK M., YETİŞİR A. E., KURTARAN B., et al.

7. Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018, (Summary Text)

33. AKCiĞER ADENOKARSiNOMUNDA C-MET AMPLiFiKASYONU VE KRiZOTiNiB TEDAViSi OLGU SUNUMU

YETİŞİR A. E., PAYDAŞ S., BÜYÜKŞİMŞEK M., OĞUL A., TOHUMCUOĞLU M.

7. Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018, (Summary Text)

34. G-CSF RELATED HEMOPHAGOCYTOSIS IN A CASE WITH LYMHPHOMA

KARAALİOĞLU B., PAYDAŞ S., YETİŞİR E., MİRİLİ C., ISMAYİLOV E., BÜYÜKŞİMŞEK M., et al.

7. Türk Tıbbi Onkoloji Kongresi, Turkey, 21 - 25 March 2018, (Summary Text)

35. Renal Primitif Nöroektodermal Tümör Olgu Sunumu

YETİŞİR A. E., PAYDAŞ S., BÜYÜKŞİMŞEK M., OĞUL A.

Ulusal İmmunoterapi ve Onkoloji Kongresi, Turkey, 25 - 29 October 2017, (Summary Text)

36. MİKROBİYOTA, SAĞLIK VE HASTALIK

PAYDAŞ S., KILIÇ BAĞIR E., DEVECİ M. A., GÖNLÜŞEN G.

ICOHE, 7 - 09 December 2017, (Summary Text)

37. Programmed Death-1 (PD-1), Programmed Death-Ligand 1 (PD-L1) Expression in Uterine Carcinosarcomas.

KÜÇÜKGÖZ GÜLEÇ Ü., KILIÇ BAĞIR E., PAYDAŞ S., SEYDAOĞLU G., GÜMÜRDÜLÜ D., GÜZEL A. B., et al.

20’th European Society of Gynecologic Oncology (ESGO) Congress 2017, Vianna, Austria., 4 - 07 November 2017, (Summary Text)

38. NÜKS/REFRAKTER HODGKİN LENFOMA VAKALARINDABRENTUXİMAB VEDOTİN’İN UZUN DÖNEM SONUÇLARI:ÇOK MERKEZLİ TÜRKİYE DENEYİMİ

FERHANOĞLU A. B., salihoğlu a., ÖZBALAK M., SOYSAL T., KARADOĞAN İ., PAYDAŞ S., et al.

43. ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 1 - 04 November 2017, (Full Text)

39. Programmed Death-1 (PD-1), Programmed Death Ligand 1(PD-L1) Expression in Type 2 Endometrial Cancer.

KÜÇÜKGÖZ GÜLEÇ Ü., KILIÇ BAĞIR E., PAYDAŞ S., SEYDAOĞLU G., GÜMÜRDÜLÜ D., GÜZEL A. B., et al.

20’th European Society of Gynecologic Oncology (ESGO) Congress, 4 - 07 November 2017, (Summary Text) Sustainable Development

40. Programmed Death-1 (PD-1), Programmed Death-Ligand 1 (PD-L1) Expression in Uterine Grade 3 Endometrioid Adenocarcinoma.

KÜÇÜKGÖZ GÜLEÇ Ü., KILIÇ BAĞIR E., PAYDAŞ S., SEYDAOĞLU G., GÜMÜRDÜLÜ D., GÜZEL A. B., et al.

20’th European Society of Gynecologic Oncology (ESGO) Congress 2017, Vianna, Austria., 3 - 07 November 2017, (Summary Text)

41. Paratiroid karsinomlu, hiperkalsemik hastada perkutanalkol enjeksiyonu seçeneği

OĞUL A., PAYDAŞ S., yetişir a. e., BÜYÜKŞİMŞEK M., MİRİLİ C.

Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 25 - 29 October 2017, (Summary Text)

42. Prephase tedavinin yüksek tümör yükü olan lenfomalıhastalarda tümör lizis sendromunu önlemede etkinliği.

OĞUL A., PAYDAŞ S., yetişir a. e., MİRİLİ C., BÜYÜKŞİMŞEK M., GÖKÇAY S.

Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 25 - 29 October 2017, (Summary Text)

43. Nüks veya Refrakter Hodgkin Lenfoma Hastalarında Nivolumab Kullanımı Türkiye Verileri

FERHANOĞLU B., BEKÖZ H. S., KARADURMUŞ N., PAYDAŞ S., TÜRKER A., TOPTAŞ T., et al.

43. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)

44. Sarkomlarda PD-1 ve PD-L1 ekspresyonunun klinik ve prognostik önemi

27. Ulusal Türk Ortopedi ve Travmatoloji Kongresi, Antalya, Turkey, 25 - 29 October 2017, vol.51, pp.122, (Summary Text)

45. Mastektomi Operasyonu Geçirmiş Meme Kanserli Kadınlarda Ağrının Değerlendirilmesi

ÖZTUNÇ G., YEŞİL DEMİRCİ P., TAŞCI S., PAYDAŞ S.

19. Ulusal İç Hastalıkları Kongresi, Turkey, 11 - 15 October 2017, (Summary Text) Sustainable Development

46. MASTEKTOMİ OPERASYONU GEÇ?İRMİŞ MEME KANSERLİ KADINLARDA AĞRININ DEĞERLENDİRİLMESİ

ÖZTUNÇ G., YEŞİL DEMİRCİ P., TAŞCI S., PAYDAŞ S.

19. Ulusal İç Hastalıkları Kongresi, Antalya, Turkey, 11 - 15 October 2017, pp.325-326, (Full Text) Sustainable Development

47. Vitamin D gene polymorphism in multiple myeloma, chron,c lymphocytic leukemia and chromic myeloid leukemia

tombal a., ay M. E., Erdal M. E., Doğru G., Söylemez M., GÜRKAN E., et al.

9th international conference on leukemia and hematologic malignancy, 5 - 06 October 2017, (Summary Text)

48. Vitamin D gene polymorphism in multiple myeloma, chronic lymphocytic leukemia and chronic myeloid leukemia

TOMBAK A., AY M. E., ERDAL M. E., DOĞRU ÖZDEMİR G., SÖYLEMEZ F., GÜRKAN E., et al.

9th International Conference on Leukemia and Hematologic Oncology, London, Canada, 5 - 06 October 2017, vol.5, (Summary Text)

49. Meta-analysis Of The Effect Of Rituximab İn The Treatment Of Primary Central Nervous SystemLymphoma

YAVUZ S., YILDIRIM M., YAZICI G., kaya v., PAYDAŞ S.

ESMO, 8 - 12 September 2017, (Summary Text)

50. PD-1 and PD-L1 expression in thymic lesions

KILIÇ BAĞIR E., AÇIKALIN A., AVCI A., GÜMÜRDÜLÜ D., PAYDAŞ S.

29th european congress of pathology, Amsterdam, Netherlands, 2 September - 06 December 2017, vol.471, pp.264, (Summary Text)

51. Türkiye’den Çok Merkezli Erken Erişim Program Sonuçları: Daha Önce Yoğun Tedavi Almış Relaps/Refrakter Multipl Miyelom Hastalarında Daratumumabın Etkililik ve Güvenliliği

BEKSAÇ M., GOKER H., TURGUT M., AYDIN Y., BESİSİK S., Cagirgan S., et al.

Türk Hematoloji Derneği, Turkey, 17 - 20 August 2017, (Summary Text)

52. The Evaluatıon of Hopelessness and Perceived Social Support Level in Patients with Lung Cancer

Bozdoğan Yeşilot S., Öztunç G., Yeşil Demirci P., İnel Manav A., Paydaş S.

18th International Conference on Nursing Midwifery (ICNM), Roma, Italy, 10 - 11 June 2017, pp.47-48, (Summary Text)

53. The Evaluation of Hopelessness and Perceived Social Support Level in Patients with Lung Cancer

BOZDOĞAN S., ÖZTUNÇ G., YEŞİL DEMİRCİ P., İNEL MANAV A., PAYDAŞ S.

18th International Conference on Nursing & Midwifery (ICNM), Roma, Italy, 10 - 11 June 2017, pp.26, (Summary Text) Sustainable Development

54. Effectiveness of bendamustine in relapse or refractory lymphoma cases: A report from Turkey-The Turkish Oncology Group (TOG) study.

Karadurmus N., Paydas S., Ocal R., Yildiz B., Nayir E., Dogan M., et al.

53rd Annual Clinical Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text)

55. RAI Tedavisi Sonrası Gelişen Eozinofilik Myeloid Neoplazi ve Lenfoblastik Lenfoma Birlikteliği

BÜYÜKŞİMŞEK M., YETİŞİR A. E., OĞUL A., GÖKÇAY S., MİRİLİ C., PAYDAŞ S.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017, (Summary Text)

56. Real World Experience: Nivolumab Expanded Access Program in Turkey

MİRİLİ C., PAYDAŞ S., GÖKÇAY S., OĞUL A., BÜYÜKŞİMŞEK M., YETİŞİR A. E.

22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017, (Summary Text)

57. RAI TEDAVİSİ SONRASI GELİŞEN EOZİNOFİLİKMYELOİD NEOPLAZİ VE LENFOBLASTİK LENFOMA BİRLİKTELİĞİ

BÜYÜKŞİMŞEK M., yetişir a. e., OĞUL A., GÖKÇAY S., MİRİLİ C., PAYDAŞ S.

22. ULUSAL KANSER KONGRESİ, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)

58. Endometrium Kanserli Olgularda Preoperatif Monosit Sayısı Nötrofil Lenfosit Oranı Ortalama Trombosit Hacmi Ortalama Trombositsayısının Trombosit Sayısına Oranı Trombosit Lenfosit Oranının Prognostik Önemi

TEMUR İ., KÜÇÜKGÖZ GÜLEÇ Ü., PAYDAŞ S., KHATİB G., VARDAR M. A., GÜZEL A. B.

15. Ulusal Jinekolojik Onkoloji Kongresi, Turkey, 30 November - 04 December 2016 Sustainable Development

59. Asingle Instutition Radical Surgery Results in Stage IB2 IIA2 Bulky Cervical Cancer

KHATİB G., KÜÇÜKGÖZ GÜLEÇ Ü., GÜZEL A. B., UYGUR B., VARDAR M. A., GÜMÜRDÜLÜ D., et al.

15. Ulusal Jinekolojik Onkoloji Kongresi, Turkey, 30 November - 04 December 2016 Sustainable Development

60. Castleman hastalığına eşlik eden pulmoner hyalinize granülom nadir bir olgu sunumu

AÇIKALIN A., GÜMÜRDÜLÜ D., ERGİN M., KILIÇ BAĞIR E., AVCI A., ÖZYILMAZ SARAÇ E., et al.

26. ulusal patholoji kongresi, Antalya, Turkey, 2 - 06 November 2016, (Summary Text)

61. Timik orjinli lezyonlarda PD1 ve PD L1 ekspresyonu

KILIÇ BAĞIR E., AÇIKALIN A., AVCI A., GÜMÜRDÜLÜ D., PAYDAŞ S.

26. Ulusal Patoloji Kongresi, Antalya, Turkey, 2 - 06 November 2016, (Summary Text)

62. Hodgkin lenfomada PD 1 ve PD L1 ekspresyonlarının tanı ve relaps durumunda değişimi İmmunoterapi ve dinamik süreç

42. Ulusal Hematoloji Kongresi, Turkey, 19 - 23 October 2016, (Full Text)

63. T hücreli lenfomada yenilikler klinisyen gözüyle

ZORLUDEMİR S., ERDOĞAN Ş., PAYDAŞ S.

Klinisyen Patolog ortak Lenfoma kursu, Turkey, 18 October 2016, (Full Text)

64. Pulmonary hyalinizing granuloma with Castleman s Disease A rarecase report

AÇIKALIN A., GÜMÜRDÜLÜ D., ERGİN M., KILIÇ BAĞIR E., AVCI A., ÖZYILMAZ SARAÇ E., et al.

XXXI International Congress of the International Academy of Pathologyand28th Congress of the European Society of Pathology, 25 - 29 September 2016

65. pulmanary hyalinizing granuloma with castlemans disease a rare case report

AÇIKALIN A., GÜMÜRDÜLÜ D., ERGİN M., KILIÇ BAĞIR E., AVCI A., ÖZYILMAZ SARAÇ E., et al.

XXXI international congress of the iap and 28th congress of ESP, köln, Germany, 25 - 29 September 2016

66. Human Herper Virus 8 related Kaposi sarcoma of the ureter after renal transplantation

XXXI International Congress of theInternational Academy of Pathologyand28th Congress of theEuropean Society of Pathology, 25 - 29 September 2016

67. Pulmonary hyalinazing granuloma with castleman s disease a rare case report

AÇIKALIN A., GÜMÜRDÜLÜ D., ERGİN M., KILIÇ BAĞIR E., AVCI A., ÖZYILMAZ SARAÇ E., et al.

XXXI International Congress of the IAP and 28th Congress of the ESP, köln, Germany, 25 - 29 September 2016, (Summary Text)

68. Evaluation of Castleman disease A series of 50 cases

KILIÇ BAĞIR E., AÇIKALIN A., PAYDAŞ S., ERGİN M.

XXXI International Congress of the IAP and 28th Congress of the ESP, Köln, Germany, 25 - 29 September 2016, (Summary Text)

69. CLINICAL OTCOMES OF THE SARCOMAS IN HEAD AND NECK

SÜRMELİOĞLU Ö., PAYDAŞ S., TUNCER Ü., ATEŞ K., KÜPELİ S., ÖZDEMİR S., et al.

7th European Conference on Head and Neck Oncology, 7 - 10 September 2016, (Full Text)

70. Does Preoperative To Lymphocyte or platalet to lymphocyte ratios have a role in predicting borderline ovarian tumors

KHATIB G., VARDAR M. A., GÜZEL A. B., KÜÇÜKGÖZ GÜLEÇ Ü., GÜMÜRDÜLÜ D., PAYDAŞ S.

ESGO PREVENTİON GYNAECOLOGICAL MALGNANCIES, 8 - 10 September 2016, vol.26, pp.32, (Summary Text)

71. clinical outcomes of the sarcomas in head and neck

SÜRMELİOĞLU Ö., PAYDAŞ S., TUNCER Ü., ateş k., ÖZDEMİR S., TARKAN Ö., et al.

ECHNO 2016, 7 - 10 September 2016

72. CLİNİCAL OUTCOMES OF THE SARCOMAS İN HEAD AND NECK

SÜRMELİOĞLU Ö., PAYDAŞ S., TUNCER Ü., ERDOĞAN K. E., KÜPELİ S., ÖZDEMİR S., et al.

7th European Conference on Head and Neck Oncology (ECHNO), 7 - 10 September 2016, (Full Text)

73. CLINICAL AND PATHOLOGIC RESULTS OF DENOSUMABTREATMENT FOR GIANT CELL TUMORS OF BONE PROSPECTIVE STUDY ON 14 CASES

DEVECİ M. A., PAYDAŞ S., GÖNLÜŞEN G., ÖZKAN C., BİÇER Ö. S., TEKİN M.

37th SICOT ORTHOPAEDİCS WORLD CONGRESS 2016, 8 - 10 September 2016, pp.52, (Summary Text)

74. The value of preoperative neutrophile to lymphocyte or platelet to lymphocyte ratios in predicting borderline ovarian tumors

KHATİB G., VARDAR M. A., GÜZEL A. B., KÜÇÜKGÖZ GÜLEÇ Ü., GÜMÜRDÜLÜ D., PAYDAŞ S.

PREVENTION IN GYNECOLOGICAL CANCER, 8 - 10 September 2016, (Full Text)

75. Gemcitabine, Vınorelbine and prednısolone (GVP)rituxımab combination ın relaps refractory lymphoma cases retrospetive analysıs